Detecting Changes in Arterial Blood Volume and Cardiac Efficiency

Recruiting now

Conditions studied: Aortic Valve Stenosis

In brief

The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.

Key facts

Study ID

NCT07205341

Run by

HemoCept Inc.

People needed

20

Starts

2025-04-29

Expected to finish

2026-09-01

Last updated by the study team

2026-04-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
• Subjects can be any gender but must be between (and including) the ages of 18 and 80.
• Subject ls being treated by the participating healthcare facility .
• ., Subject requires a trans-aortic valve replacement.
• Subject is able and willing to provide informed consent and HIPM authorization.
• Subject is able and willing to meet all study requirements.

You may not qualify if…

• Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
• Subject has a personal medical history that includes:
• Long O-T syndrome
• Cardiac channelopathies
• Seizures

Where it is running

• Boulder Heart — Boulder, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.